Related Experiment Videos
The new Philippine Generic Drugs Act: a physician's viewpoint
1Clinical Epidemiology Unit, University of the Philippines--Philippine General Hospital, Manila.
Journal of Clinical Epidemiology
|January 1, 1991
Summary
Most Filipino physicians oppose the Generics Act of 1988 due to concerns about drug quality. Government assurance of generic drug quality and physician education are crucial for the Act
Area of Science:
- Health Policy
- Pharmaceutical Sciences
- Public Health
Background:
- The Philippine Generics Act of 1988 was enacted to improve access to affordable and effective medicines.
- The Act has faced significant debate among local and international health professionals.
- Physician perspectives are critical for understanding the practical impact of pharmaceutical policies.
Purpose of the Study:
- To evaluate the knowledge, attitude, and practice (KAP) of physicians regarding the Generics Act of 1988.
- To identify barriers to the successful implementation of the Generics Act.
- To assess physician confidence in regulatory bodies overseeing generic drug quality.
Main Methods:
- A preliminary evaluation of a survey assessing physician KAP towards the Generics Act.
- Analysis of physician attitudes concerning the Bureau of Food and Drugs' capacity to ensure generic drug quality.
Main Results:
- A significant majority (70%) of surveyed physicians expressed opposition to the Generics Act.
- Most opposing physicians cited concerns about the Bureau of Food and Drugs' ability to guarantee generic drug quality.
- Physician confidence in regulatory oversight is a key factor influencing their stance on the Act.
Conclusions:
- Physician opposition to the Generics Act is substantial, primarily driven by quality concerns.
- Effective implementation hinges on the government's demonstrated ability to ensure generic drug quality.
- Disseminating accurate information to physicians is essential for fostering acceptance and compliance with the Act.